← Back to Screener
BeyondSpring Inc. Ordinary Shares (BYSI)
Price$1.74
Value ScoreD
Momentum ScoreB
Favorite Metrics
Price vs S&P 500 (26W)-22.67%
Price vs S&P 500 (4W)13.11%
VGM Score43.41
Market Capitalization$69.90M
All Metrics
Book Value / Share (Quarterly)$0.21
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.46
Price vs S&P 500 (YTD)-7.09%
Net Profit Margin (TTM)-4750.48%
EPS (TTM)$-0.19
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$-0.19
EPS (Annual)$-0.02
ROI (Annual)-227.16%
Net Profit Margin (5Y Avg)-9233.73%
Cash / Share (Quarterly)$0.19
ROA (Last FY)-3.88%
EBITD / Share (TTM)$-0.21
ROE (5Y Avg)-174.61%
Operating Margin (TTM)-4903.03%
Cash Flow / Share (Annual)$-0.48
P/B Ratio8.62x
P/B Ratio (Quarterly)6.92x
Net Income / Employee (Annual)$-22,900
EV / Revenue (TTM)48.75x
Net Interest Coverage (TTM)-236.00x
ROA (TTM)-29.15%
EPS Incl Extra (Annual)$-0.02
Current Ratio (Annual)1.54x
Quick Ratio (Quarterly)1.06x
3-Month Avg Trading Volume0.02M
52-Week Price Return4.29%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-0.15
P/S Ratio (Annual)51.74x
Asset Turnover (Annual)0.03x
52-Week High$3.44
Operating Margin (5Y Avg)-9191.78%
EPS Excl Extra (Annual)$-0.02
CapEx CAGR (5Y)-0.78%
26-Week Price Return-9.09%
Quick Ratio (Annual)1.52x
13-Week Price Return24.09%
Total Debt / Equity (Annual)0.06x
Current Ratio (Quarterly)1.09x
Enterprise Value$65.87M
Asset Turnover (TTM)0.01x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-2673.35%
Cash / Share (Annual)$0.31
3-Month Return Std Dev76.20%
Net Income / Employee (TTM)$-173,700
ROE (Last FY)-240.51%
Net Interest Coverage (Annual)-29.23x
EPS Basic Excl Extra (Annual)$-0.02
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.06x
EPS Incl Extra (TTM)$-0.19
ROI (TTM)-128.17%
P/S Ratio (TTM)51.74x
Pretax Margin (5Y Avg)-9104.20%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$-0.15
Forward P/E0.86x
Price vs S&P 500 (52W)-23.86%
Year-to-Date Return4.29%
5-Day Price Return-0.58%
EPS Normalized (Annual)$-0.02
ROA (5Y Avg)-54.33%
Net Profit Margin (Annual)-2463.29%
Month-to-Date Return1.19%
EBITD / Share (Annual)$-0.22
Operating Margin (Annual)-2756.40%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-170.11%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.19
P/B Ratio (Annual)6.64x
Pretax Margin (TTM)-4784.46%
Book Value / Share (Annual)$0.69
Price vs S&P 500 (13W)13.42%
Beta0.38x
Revenue / Share (TTM)$0.00
ROE (TTM)-133.13%
52-Week Low$1.18
vGradeD
mGradeB
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.05est. —
Analyst Recommendations
Mar 2024
Apr 2024
May 2024
Jun 2024
4.29
4.29
4.29
4.29
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BYSIBeyondSpring Inc. Ordinary Shares | D | — | B | $1.74 |
| LLYEli Lilly & Co. | D | B | B | $1078.78 |
| JNJJohnson & Johnson | C | C | C | $223.24 |
| ABBVABBVIE INC. | D | C | C | $217.13 |
| MRKMerck & Co., Inc. | C | C | C | $114.70 |
| AZNAstraZeneca PLC | D | B | C | $176.28 |
| NVSNovartis AG | C | C | C | $143.66 |
| NVONovo-Nordisk A/S | B | B | B | $42.00 |
| ABTAbbott Laboratories | C | C | D | $86.99 |
| PFEPfizer Inc. | B | C | C | $25.34 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $32.83 |
About
BeyondSpring Inc is a clinical-stage biopharmaceutical company developing cancer therapies with a focus on immuno-oncology. The company's lead program, Plinabulin, is an investigational agent in clinical development for oncology indications.